Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adipose Tissue
Research from Q. Liu and co-researchers yields new findings on adipose tissue
March 9th, 2008
In this recent report published in the journal Acta Pharmacologica Sinica, researchers in Shanghai, People's Republic of China conducted a study "To characterize the in vitro bioactivities of rhodanine derivatives as novel peroxisome proliferator-activated receptor (PPAR) gamma modulators, based on a hit (SH00012671) identified during high-throughput screening (HTS) of a diverse synthetic compound library, and to preliminarily elucidate the structure-activity relationship of this class of PPAR gamma agonists. Full-length PPAR gamma and retinoid X receptor alpha (RXR alpha), biotinylated PPAR response element (PPRE), [H-3]BRL49653 (rosiglitazone), and streptavidin-coated FlashPlate...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-09)
|
